Skip to main content

Emory researchers: 'Very encouraging' results in Covid-19 vaccine phase 1 trial

The vaccine produced "a good immune response," and trial participants suffered no serious adverse events, investigators reported. The second phase of the trial is ongoing and a third phase will launch this month.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.